Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended chemotherapy during the waiting period before surgery for rectal cancer
ACTRN12611000339954Phase 3Recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Apr 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluorouracil and folinic acid in rectal cancer and rectal adenocarcinoma (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoints: Complete clinical response and Complete pathological response. Started Apr 2011; status: recruiting.
02
Drugs
fluorouracilfolinic acid
03
Conditions
rectal cancerrectal adenocarcinoma
Beyond the preview
Go deeper on ACTRN12611000339954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000339954.